Skip to main content

Author: Bill Snyder

Study explores how bacteria become drug resistant

Jan. 6, 2022—Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs.

Read more


Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness

Dec. 23, 2021—On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.

Read more


“Atlas” of lung development may aid efforts to heal premature lungs

Dec. 20, 2021—Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time.

Read more


Silver appointed to national committee assessing human requirements for energy intake and expenditure

Dec. 17, 2021—Vanderbilt's Heidi Silver, PhD, RDN, MS, has been appointed to an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine to assess the human requirements for energy intake and expenditure.

Read more


Two VUMC papers named among genomic medicine’s top 10

Dec. 16, 2021—Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.

Read more


“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Dec. 10, 2021—Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

Read more


VUMC expresses appreciation to NIH director Francis Collins on his retirement 

Dec. 10, 2021—VUMC joins health leaders from across the country in applauding Francis Collins, M.D., Ph.D., for his 12-plus years of service as director of the National Institutes of Health. Collins, a physician-geneticist and the longest serving presidentially appointed NIH director, will retire at the end of the year. Since his appointment in August 2009, the annual...

Read more


Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

Dec. 9, 2021—The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Read more


Gene discoveries give new hope to people who stutter

Dec. 2, 2021—New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.

Read more


VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Nov. 23, 2021—Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.

Read more


Seven from VUMC among most highly cited researchers

Nov. 18, 2021—Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

Read more


The power of white matter

Nov. 11, 2021—Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more